Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Health Wire Taiwan.
Health Insurance Technology Market Set for Explosive Growth: Collective Health, Devoted Health
EIN Presswire
·
July 20, 2024
The Financial Institutions Compliance Training market size is estimated to increase by USD at a CAGR of 16.81% by 2030. PUNE, MAHARASHTRA, INDIA, July 20, 2024 /EINPresswire.com/ -- According to HTF Market Intelligence, the Global Health...
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
GlobeNewswire, Inc.
·
November 4, 2024
WATERTOWN, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today...
Semiconductor Manufacturing Equipment Market is Expected to Grow USD 217.9 Billion by 2033 | CAGR 8.2% During 2025-2033
EIN Presswire
·
July 9, 2025
The market is driven by technological advancements, rising demand for electric vehicles and renewable energy, global supply chain shifts. BROOKLYN, NY, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- IMARC Group, a leading market research...
EyePoint Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Developments
GlobeNewswire, Inc.
·
November 7, 2024
– Announced positive interim data for DURAVYU 2.7mg in DME demonstrating meaningful, early and sustained visual acuity gains, strong anatomical control and a continued favorable safety profile; BCVA and CST improvement of +8.9 letters and -68...
EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares
GlobeNewswire, Inc.
·
October 31, 2024
WATERTOWN, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today...
Avalue Technology Launches 15.6-inch HID-1540 Medical All-in-One PC for Next-Gen Smart Healthcare
EIN Presswire
·
October 17, 2024
Avalue proudly announces the release of its latest HID-1540, a 15.6-inch medical all-in-one panel PC. TAIPEI, TAIWAN, October 17, 2024 /EINPresswire.com/ -- Avalue Technology Launches 15.6-inch HID-1540 Medical All-in-One PC for Next-Gen Smart...
EyePoint Pharmaceuticals Announces Pricing of Upsized Public Offering
GlobeNewswire, Inc.
·
October 30, 2024
WATERTOWN, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today...
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
GlobeNewswire, Inc.
·
October 28, 2024
WATERTOWN, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today...
Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024
GlobeNewswire, Inc.
·
October 25, 2024
REYKJAVIK, Iceland, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the...
Business Health Insurance Market to Set an Explosive Growth in Near Future | UnitedHealth, Anthem, Humana, Cigna
EIN Presswire
·
October 28, 2024
Stay up to date with HTF MI's Business Health Insurance Market research. Learn how key trends and emerging drivers are shaping this industry's growth. PUNE, MAHARASHTRA, INDIA, October 28, 2024 /EINPresswire.com/ -- HTF MI recently introduced...
EyePoint Pharmaceuticals Announces First Patient Dosed in Global Phase 3 LUGANO Clinical Trial of DURAVYUTM for the Treatment of Wet Age-Related Macular Degeneration
GlobeNewswire, Inc.
·
October 24, 2024
– Second Phase 3 LUCIA pivotal trial first patient dosing expected by end of 2024 – – Topline data anticipated in 2026 – WATERTOWN, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to...
Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset
GlobeNewswire, Inc.
·
October 21, 2024
The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseases Cureverse receives undisclosed...
Philippines Boosts Global Legal Aid for OFWs with New Policies and Expanded Programs
EIN Presswire
·
July 9, 2025
The Philippine government has significantly enhanced its legal assistance programs for Overseas Filipino Workers (OFWs) over the past years, unveiling policies. UNITED ARAB EMIRATES, July 9, 2025 /EINPresswire.com/ -- The Philippine government...
Costco Wholesale Corporation Reports June Sales Results
GlobeNewswire, Inc.
·
July 9, 2025
ISSAQUAH, Wash., July 09, 2025 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net sales of $26.44 billion for the retail month of June, the five weeks ended July 6, 2025, an increase of...
EyePoint Pharmaceuticals Announces Positive Interim 16-Week Data for Ongoing Phase 2 VERONA Clinical Trial of DURAVYU™ for Diabetic Macular Edema
GlobeNewswire, Inc.
·
October 28, 2024
- DURAVYU 2.7mg demonstrated an early and sustained improvement in BCVA with a gain of +8.9 letters compared to baseline - – DURAVYU 2.7mg demonstrated an early and sustained anatomical improvement mirroring BCVA results with a 68 micron reduction...
Growing Insights: Trends in the Retinal Vein Occlusion Market | Taiwan Liposome Company, Aerie Pharmaceuticals
EIN Presswire
·
October 30, 2024
New report uncovers key trends and growth opportunities in the Retinal Vein Occlusion market, focusing on innovative treatment advancements. BURLINGAME, CA, UNITED STATES, October 30, 2024 /EINPresswire.com/ -- A new report published by...
ZenaTech Creates First Quantum Computing Prototype Enabling Disruptive AI Drone Speed and Precision for Future Commercial and US Defense Applications
GlobeNewswire, Inc.
·
July 10, 2025
VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service...
President Lai names Taiwania Capital Chairman Lin Hsin-i as 2024 APEC envoy
Taiwan President News
·
October 21, 2024
TAIWAN, October 21 - President Lai names Taiwania Capital Chairman Lin Hsin-i as 2024 APEC envoy On October 21 Presidential Office Spokesperson Karen Kuo (郭雅慧) announced that President Lai Ching-te has invited Lin Hsin-i (林信義), chairman of...
Intrinseque Health Achieves Accredited GDPMDS Certification.
EIN Presswire
·
October 7, 2024
Intrinseque Health Achieves Accredited GDPMDS Certification, Recognising It's dedication To Operational Excellence and Regulatory Compliance. SINGAPORE, October 7, 2024 /EINPresswire.com/ -- Intrinseque Health’s robust Quality system for...
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire, Inc.
·
October 16, 2024
WATERTOWN, Mass., Oct. 16, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today...